Correlation Between Tumor Vasculogenic Mimicry and Poor Prognosis of Human Digestive Cancer Patients: A Systematic Review and Meta-Analysis
- PMID: 30361906
- DOI: 10.1007/s12253-018-0496-3
Correlation Between Tumor Vasculogenic Mimicry and Poor Prognosis of Human Digestive Cancer Patients: A Systematic Review and Meta-Analysis
Abstract
Vasculogenic mimicry (VM) is a new pattern of blood supplement independent of endothelial vessels, which is related with tumor invasion, metastasis and prognosis. However, the role of VM in the prognosis of cancer patients is controversial. This study aimed to perform a meta-analysis of the published data to attempt to clarify the prognostic value of VM in the digestive cancer. Relevant studies were retrieved from the PubMed, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure and VIP databases published before March 29, 2018. Studies were included if they detected VM in the digestive cancer and analyzed the overall survival (OS) or disease-free survival (DFS) according to VM status. Two independent reviewers screened the studies, extracted data, and evaluated the quality of included studies with the Newcastle-Ottawa scale. Meta-analysis was performed using STATA 12.0 software. A total of 22 studies with 2411 patients were included in this meta-analysis. Meta-analysis showed that VM was related with the poor OS (HR = 2.30, 95% CI: 2.06-2.56, P < 0.001) and DFS (HR = 2.60, 95% CI: 2.07-3.27, P < 0.001) of patients with digestive cancer. Subgroup analysis showed VM was related with tumor differentiation, lymph node metastasis and TNM stage. Moreover, the present meta-analysis was reliable, and there was no obvious publication bias. This meta-analysis suggested that VM was a poor prognosis of digestive cancer patients. Further large and well-designed studies are required.
Keywords: Vasculogenic mimicry; digestive cancer; meta-analysis; prognosis.
Similar articles
-
Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.Angiogenesis. 2016 Apr;19(2):191-200. doi: 10.1007/s10456-016-9500-2. Epub 2016 Feb 22. Angiogenesis. 2016. PMID: 26899730
-
Vasculogenic Mimicry: A Promising Prognosticator in Head and Neck Squamous Cell Carcinoma and Esophageal Cancer? A Systematic Review and Meta-Analysis.Cells. 2020 Feb 24;9(2):507. doi: 10.3390/cells9020507. Cells. 2020. PMID: 32102317 Free PMC article.
-
Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.PLoS One. 2015 Dec 28;10(12):e0145659. doi: 10.1371/journal.pone.0145659. eCollection 2015. PLoS One. 2015. PMID: 26710214 Free PMC article.
-
Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.Breast Cancer Res Treat. 2020 Jan;179(2):359-370. doi: 10.1007/s10549-019-05482-8. Epub 2019 Nov 4. Breast Cancer Res Treat. 2020. PMID: 31686261
-
Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis.J Cell Physiol. 2020 Mar;235(3):2800-2808. doi: 10.1002/jcp.29184. Epub 2019 Sep 13. J Cell Physiol. 2020. PMID: 31517399
Cited by
-
Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.Front Pharmacol. 2024 Apr 17;15:1346719. doi: 10.3389/fphar.2024.1346719. eCollection 2024. Front Pharmacol. 2024. PMID: 38694917 Free PMC article.
-
Vasculogenic mimicry in non-small cell lung cancer: a systematic review.Front Oncol. 2025 Jul 25;15:1481726. doi: 10.3389/fonc.2025.1481726. eCollection 2025. Front Oncol. 2025. PMID: 40786517 Free PMC article.
-
Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.J Cell Commun Signal. 2023 Sep;17(3):591-608. doi: 10.1007/s12079-022-00693-z. Epub 2022 Sep 5. J Cell Commun Signal. 2023. PMID: 36063341 Free PMC article.
-
Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status.BMC Cancer. 2021 Feb 6;21(1):132. doi: 10.1186/s12885-021-07863-z. BMC Cancer. 2021. PMID: 33549061 Free PMC article.
-
LINC00265 targets miR-382-5p to regulate SAT1, VAV3 and angiogenesis in osteosarcoma.Aging (Albany NY). 2020 Aug 14;12(20):20212-20225. doi: 10.18632/aging.103762. Epub 2020 Aug 14. Aging (Albany NY). 2020. Retraction in: Aging (Albany NY). 2025 Jan 31;17(1):278-279. doi: 10.18632/aging.206195. PMID: 33109774 Free PMC article. Retracted.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources